These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30538423)

  • 1. Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study.
    Economou MA; Laukeland HK; Grabska-Liberek I; Rouland JF
    Clin Ophthalmol; 2018; 12():2399-2407. PubMed ID: 30538423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis.
    Harasymowycz P; Hutnik C; Rouland JF; Negrete FJM; Economou MA; Denis P; Baudouin C
    Adv Ther; 2021 Jun; 38(6):3019-3031. PubMed ID: 33891269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials.
    Uusitalo H; Egorov E; Kaarniranta K; Astakhov Y; Ropo A
    Clin Ophthalmol; 2016; 10():445-54. PubMed ID: 27041987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma.
    Seong HJ; Lee K; Lee SJ; Kim S; Park JW
    Korean J Ophthalmol; 2021 Jun; 35(3):235-241. PubMed ID: 34120423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
    Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
    Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.
    Sanford M
    Clin Drug Investig; 2014 Jul; 34(7):521-8. PubMed ID: 24895141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.
    Park SW; Lee J; Kook MS
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
    Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
    Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial.
    Kim JM; Sung KR; Lee JW; Kyung H; Rho S; Kim CY
    Int J Ophthalmol; 2021; 14(10):1539-1547. PubMed ID: 34667730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial.
    Kim DW; Shin J; Lee CK; Kim M; Lee S; Rho S
    Sci Rep; 2021 Jul; 11(1):14971. PubMed ID: 34294842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study].
    Denis P;
    J Fr Ophtalmol; 2016 Sep; 39(7):622-30. PubMed ID: 27567675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
    Aptel F; Choudhry R; Stalmans I
    Curr Med Res Opin; 2016 Aug; 32(8):1457-63. PubMed ID: 27310103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients.
    Ruangvaravate N; Choojun K; Srikulsasitorn B; Chokboonpiem J; Asanatong D; Trakanwitthayarak S
    Clin Ophthalmol; 2020; 14():3109-3119. PubMed ID: 33116362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.
    Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):515-23. PubMed ID: 22671995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension.
    Aptel F; Pfeiffer N; Schmickler S; Clarke J; Lavín-Dapena C; Moreno-Montañés J; Żarnowski T; Csutak A; Jugaste T; Volksone L; Astakhov YS; Coupier L; Nordmann JP; Stalmans I;
    J Glaucoma; 2019 Jun; 28(6):498-506. PubMed ID: 31166287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability in Glaucoma Patients Switched from Preserved to Preservative-Free Prostaglandin-Timolol Combination: A Prospective Real-Life Study.
    Jandroković S; Vidas Pauk S; Lešin Gaćina D; Skegro I; Tomić M; Masnec S; Kuzman T; Kalauz M
    Clin Ophthalmol; 2022; 16():3181-3192. PubMed ID: 36196405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male guinea pigs following repeated exposure.
    Ali AF; Salama RM; Soliman MA
    Folia Morphol (Warsz); 2022; 81(1):52-64. PubMed ID: 33438192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.
    Kestelyn PA; Kestelyn PG; De Bacquer D; Stevens AM
    Int Ophthalmol; 2019 Jan; 39(1):105-109. PubMed ID: 29274019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.
    Bourne RRA; Kaarniranta K; Lorenz K; Traverso CE; Vuorinen J; Ropo A
    BMJ Open; 2019 Apr; 9(4):e024129. PubMed ID: 30944129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.